The Future of Respiratory Monitoring Starts with NanoIn
Asthma management has remained largely unchanged for decades. Traditional inhalers deliver medication effectively—but they provide no insight into how, when, or how well the therapy is being used.
NanoIn is redefining this paradigm.
NanoIn introduces a next-generation smart asthma inhaler equipped with an embedded microchip and Bluetooth connectivity, converting a conventional inhaler into an intelligent, connected medical device.
From Medication Delivery to Data-Driven Care
The NanoIn smart inhaler captures real-time inhalation data, including:
- Actuation timing
- Usage frequency
- Adherence patterns
- Inhalation consistency
Through secure Bluetooth transmission, this information is synchronized with a digital health platform, enabling continuous monitoring and advanced analytics.
This transforms asthma treatment from reactive symptom management into proactive, precision-based respiratory care.
Clinical Impact
Asthma outcomes are often compromised by poor adherence and incorrect inhaler technique—issues that frequently go undetected between clinical visits.
NanoIn addresses this gap by enabling:
- Objective, real-world usage tracking
- Early identification of non-adherence
- Data-supported clinical decision-making
- Remote patient monitoring
- Reduced risk of preventable exacerbations
By bridging the gap between patient behavior and clinical oversight, NanoIn empowers healthcare providers with actionable insights rather than assumptions.
Built for the Modern Healthcare Ecosystem
NanoIn is designed with scalability, interoperability, and regulatory readiness in mind. The platform supports integration with digital health infrastructures, remote care systems, and value-based healthcare models.
Our vision extends beyond a smart device.
We are building a connected respiratory care ecosystem that enhances outcomes, improves efficiency, and supports personalized treatment strategies.